165 related articles for article (PubMed ID: 34559050)
1. MRI and CT in the follow-up after irreversible electroporation of small renal masses.
Buijs M; de Bruin DM; Wagstaff PG; J Zondervan P; Scheltema MJ; W Engelbrecht M; P Laguna M; van Lienden KP
Diagn Interv Radiol; 2021 Sep; 27(5):654-663. PubMed ID: 34559050
[TBL] [Abstract][Full Text] [Related]
2. Feasibility and safety of irreversible electroporation (IRE) in patients with small renal masses: Results of a prospective study.
Buijs M; Zondervan PJ; de Bruin DM; van Lienden KP; Bex A; van Delden OM
Urol Oncol; 2019 Mar; 37(3):183.e1-183.e8. PubMed ID: 30509869
[TBL] [Abstract][Full Text] [Related]
3. Irreversible electroporation for the treatment of localized prostate cancer: a summary of imaging findings and treatment feedback.
Scheltema MJ; Postema AW; de Bruin DM; Buijs M; Engelbrecht MR; Laguna MP; Wijkstra H; de Reijke TM; de la Rosette JJMCH
Diagn Interv Radiol; 2017; 23(5):365-370. PubMed ID: 28830850
[TBL] [Abstract][Full Text] [Related]
4. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
[TBL] [Abstract][Full Text] [Related]
5. Irreversible Electroporation for the Ablation of Renal Cell Carcinoma: A Prospective, Human, In Vivo Study Protocol (IDEAL Phase 2b).
Buijs M; van Lienden KP; Wagstaff PG; Scheltema MJ; de Bruin DM; Zondervan PJ; van Delden OM; van Leeuwen TG; de la Rosette JJ; Laguna MP
JMIR Res Protoc; 2017 Feb; 6(2):e21. PubMed ID: 28209559
[TBL] [Abstract][Full Text] [Related]
6. A retrospective study of CT-guided percutaneous irreversible electroporation (IRE) ablation: clinical efficacy and safety.
Wang Z; Lu J; Huang W; Wu Z; Gong J; Wang Q; Liu Q; Wang C; Zhu Y; Ding X; Wang Z
BMC Cancer; 2021 Feb; 21(1):124. PubMed ID: 33546635
[TBL] [Abstract][Full Text] [Related]
7. MR and CT imaging characteristics and ablation zone volumetry of locally advanced pancreatic cancer treated with irreversible electroporation.
Vroomen LGPH; Scheffer HJ; Melenhorst MCAM; de Jong MC; van den Bergh JE; van Kuijk C; van Delft F; Kazemier G; Meijerink MR
Eur Radiol; 2017 Jun; 27(6):2521-2531. PubMed ID: 27659702
[TBL] [Abstract][Full Text] [Related]
8. Upper-Urinary-Tract Effects After Irreversible Electroporation (IRE) of Human Localised Renal-Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Ablate-and-Resect Study.
Wendler JJ; Pech M; Köllermann J; Friebe B; Siedentopf S; Blaschke S; Schindele D; Porsch M; Baumunk D; Jürgens J; Fischbach F; Ricke J; Schostak M; Böhm M; Liehr UB
Cardiovasc Intervent Radiol; 2018 Mar; 41(3):466-476. PubMed ID: 28929209
[TBL] [Abstract][Full Text] [Related]
9. Minimally Invasive Percutaneous Treatment of Small Renal Tumors with Irreversible Electroporation: A Single-Center Experience.
Trimmer CK; Khosla A; Morgan M; Stephenson SL; Ozayar A; Cadeddu JA
J Vasc Interv Radiol; 2015 Oct; 26(10):1465-71. PubMed ID: 26250855
[TBL] [Abstract][Full Text] [Related]
10. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial).
Wendler JJ; Porsch M; Nitschke S; Köllermann J; Siedentopf S; Pech M; Fischbach F; Ricke J; Schostak M; Liehr UB
Contemp Clin Trials; 2015 Jul; 43():10-9. PubMed ID: 25962890
[TBL] [Abstract][Full Text] [Related]
11. Irreversible Electroporation for the Treatment of Small Renal Masses: 5-Year Outcomes.
Dai JC; Morgan TN; Steinberg RL; Johnson BA; Garbens A; Cadeddu JA
J Endourol; 2021 Nov; 35(11):1586-1592. PubMed ID: 33926224
[No Abstract] [Full Text] [Related]
12. Initial Assessment of the Efficacy of Irreversible Electroporation in the Focal Treatment of Localized Renal Cell Carcinoma With Delayed-interval Kidney Tumor Resection (Irreversible Electroporation of Kidney Tumors Before Partial Nephrectomy [IRENE] Trial-An Ablate-and-Resect Pilot Study).
Wendler JJ; Pech M; Fischbach F; Jürgens J; Friebe B; Baumunk D; Porsch M; Blaschke S; Schindele D; Siedentopf S; Ricke J; Schostak M; Köllermann J; Liehr UB
Urology; 2018 Apr; 114():224-232. PubMed ID: 29305201
[TBL] [Abstract][Full Text] [Related]
13. First Delayed Resection Findings After Irreversible Electroporation (IRE) of Human Localised Renal Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Trial.
Wendler JJ; Ricke J; Pech M; Fischbach F; Jürgens J; Siedentopf S; Roessner A; Porsch M; Baumunk D; Schostak M; Köllermann J; Liehr UB
Cardiovasc Intervent Radiol; 2016 Feb; 39(2):239-50. PubMed ID: 26341653
[TBL] [Abstract][Full Text] [Related]
14. [Irreversible electroporation: local, non-thermal, ablation therapy of malignant tumours].
Janík V; Skrabalová D; Gürlich R; Málek J
Cas Lek Cesk; 2013; 152(2):67-75. PubMed ID: 23641678
[TBL] [Abstract][Full Text] [Related]
15. Irreversible electroporation (IRE) in renal cell carcinoma (RCC): a mid-term clinical experience.
Wah TM; Lenton J; Smith J; Bassett P; Jagdev S; Ralph C; Vasudev N; Bhattarai S; Kimuli M; Cartledge J
Eur Radiol; 2021 Oct; 31(10):7491-7499. PubMed ID: 33825033
[TBL] [Abstract][Full Text] [Related]
16. Comparison between high-frequency irreversible electroporation and irreversible electroporation ablation of small swine liver: follow-up of DCE-MRI and pathological observations.
Li J; Zhang XB; Wang JJ; Jin LJ; Shan HS; Zhang X; Ma L; Xue XD; Zhang X; Zhang ZL; Meng LL; Yuan F; Xiao YY
Chin Med J (Engl); 2021 Jun; 134(17):2081-2090. PubMed ID: 34172620
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Chronologic Change in the Size and Contrast-Enhancement of Ablation Zones on CT Images after Irreversible Electroporation and Radiofrequency Ablation.
Scheck J; Bruners P; Schindler D; Kuhl C; Isfort P
Korean J Radiol; 2018; 19(4):560-567. PubMed ID: 29962862
[TBL] [Abstract][Full Text] [Related]
18. Irreversible Electroporation (IRE) in Renal Tumors.
Narayanan G; Doshi MH
Curr Urol Rep; 2016 Feb; 17(2):15. PubMed ID: 26769468
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of irreversible electroporation for the ablation of renal masses: a prospective, human, in-vivo study protocol.
Wagstaff PG; de Bruin DM; Zondervan PJ; Savci Heijink CD; Engelbrecht MR; van Delden OM; van Leeuwen TG; Wijkstra H; de la Rosette JJ; Laguna Pes MP
BMC Cancer; 2015 Mar; 15():165. PubMed ID: 25886058
[TBL] [Abstract][Full Text] [Related]
20. MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by radical prostatectomy.
van den Bos W; de Bruin DM; van Randen A; Engelbrecht MR; Postema AW; Muller BG; Varkarakis IM; Skolarikos A; Savci-Heijink CD; Jurhill RR; Zondervan PJ; Laguna Pes MP; Wijkstra H; de Reijke TM; de la Rosette JJ
Eur Radiol; 2016 Jul; 26(7):2252-60. PubMed ID: 26449559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
